Gore Viatorr
This article was originally published in The Gray Sheet
Executive Summary
FDA clears implantable nitinol and ePTFE endoprosthesis to treat portal hypertension in de novo and revision transjugular intrahepatic portosystemic shunt (TIPS) procedures, W.L. Gore announces Dec. 8. Viatorr was 510(k)-cleared in March 2003 for tracheobronchial strictures...